Año: 2019
Journal Impact Factor (JIF): 4.2180
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | 31/156 | Q1 | T1 | D2 |
HEMATOLOGY | SCIE | 19/76 | Q1 | T1 | D3 |
MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 40/139 | Q2 | T1 | D3 |
CELL & TISSUE ENGINEERING | SCIE | 12/29 | Q2 | T2 | D4 |
CELL BIOLOGY | SCIE | 74/195 | Q2 | T2 | D4 |
Año: 2019
Journal Citation Indicator (JCI): 1,040
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | 37/165 | Q1 | T1 | D3 | 77,88 |
CELL & TISSUE ENGINEERING | 11/31 | Q2 | T2 | D4 | 66,13 |
CELL BIOLOGY | 56/200 | Q2 | T1 | D3 | 72,25 |
HEMATOLOGY | 19/93 | Q1 | T1 | D2 | 80,11 |
MEDICINE, RESEARCH & EXPERIMENTAL | 51/187 | Q2 | T1 | D3 | 73,00 |
Año:
2019
CiteScore:
7,200
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Genetics (clinical) | 18/90 | Q1 | T1 | D2 |
Oncology | 59/331 | Q1 | T1 | D2 |
Transplantation | 5/36 | Q1 | T1 | D2 |
Immunology and Allergy | 43/180 | Q1 | T1 | D3 |
Cancer Research | 51/198 | Q2 | T1 | D3 |
Cell Biology | 70/274 | Q2 | T1 | D3 |
Immunology | 53/200 | Q2 | T1 | D3 |
SJR año:
2019
Factor de Impacto:
1,233
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Transplantation | 10/54 | Q1 | T1 | D2 |
Immunology and Allergy | 63/230 | Q2 | T1 | D3 |
Oncology | 106/419 | Q2 | T1 | D3 |
Genetics (clinical) | 34/107 | Q2 | T1 | D4 |
Immunology | 76/245 | Q2 | T1 | D4 |
Cancer Research | 85/241 | Q2 | T2 | D4 |
Cell Biology | 118/313 | Q2 | T2 | D4 |
# | Autor | Afiliación |
---|---|---|
1 | Ruprecht Karls University Heidelberg (Germany) | |
2 | Fernandez-Munoz, B | CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Lab Andaluz Reprogramac Celular LARCEL; Iniciat Andaluza Terapias Avanzadas (Spain) |
3 | Pati, S | BSI; University of California San Francisco (USA) |
4 | Goethe University Frankfurt Hospital (Germany) |